14.02.2018 • NewsElaine Burridgepetchem

Shaheen Plans $1 billion Petchem Complex in UAE

Shaheen Chem Investment, is planning to invest Dh4 billion, or around $1...
Shaheen Chem Investment, is planning to invest Dh4 billion, or around $1 billion, to build a chemical complex in Abu Dhabi. (c) mmmx/Shutterstock

Shaheen Chem Investment, owned by investors from the United Arab Emirates (UAE) and Oman, is planning to invest Dh4 billion, or around $1 billion, to build a chemical complex in Abu Dhabi.

The company has signed an agreement with the Khalifa Industrial Zone of Abu Dhabi (Kizad) to lease land for a two-stage complex that is intended to support the UAE’s expanding chemical industry.

In a first phase, Shaheen will build a plant to produce 130,000 t/y of caustic soda and 160,000 t/y of ethylene dichloride (EDC). The facility will supply caustic soda raw material to the Al Taweelah alumina refinery operated by Emirates Global Aluminium (EGA).

The second phase will include a doubling of caustic soda capacity and extending operations to include production of vinyl chloride and PVC. A timescale for both stages of the project was not disclosed.

Shaheen’s chairman, Rashed Al Suwaidi, said the company was excited to become the first producer of EDC in the UAE.

The zone is reported to have attracted investors from countries such as China, Japan, India and Brazil among others since it opened in 2012.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read